As a population of adult stem cells, endothelial progenitor cells (EPC) have been focused on by many researchers in these years. However, most of studies on EPCs are on cardiovascular disease instead of stroke. It was found that EPC could be a biomarker of cardiovascular risk and EPC transplantation or regulation of EPC mobilization may play a role in the therapy of stroke. In this review, we will summarize the developments of researches on EPC and stroke.